Rhydburg Pharmaceuticals Ltd, a active public limited company, was established on 26 June 1987 in Delhi, Delhi, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24231DL1987PLC028434. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹5.00 Cr and a paid-up capital of ₹3.70 Cr.
It upholds a compliant status. Employing 200 professional, Its leadership includes Vinod Thapar (Director), Seema Monga (Whole-Time Director), Sovan Lal Subalchand Pal (Director). Past directors included Prateek Monga, Akshay Monga, Daljeet Singh. It holds ₹8.50 Cr open charges and ₹39.60 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at B-9, 1St Floor, Commercial Complex Dr. Mukharjee Nagar, Delhi-110009, Delhi, Delhi, 110009.
U24231DL1987PLC028434
028434
26 June 1987
₹5.00 Cr
₹3.70 Cr
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Rhydburg Pharmaceuticals Ltd — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vinod Thapar | Director | 22 Feb 2018 | Current |
| Seema Monga | Whole-Time Director | 22 Feb 2018 | Current |
| Sovan Lal Subalchand Pal | Director | 04 Jun 2025 | Current |
| Ashok Monga | Whole-Time Director | 15 Dec 1993 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 26 Feb 2018 | Past |
| Pramod Abcsdd | Additional Director | 26 Feb 2018 | Past |
| Pramod Abcsdd | Director | 20 Sep 2006 | Past |
| Pramod Abcsdd | Director | 07 Feb 2018 | Past |
| Pramod Abcsdd | Director | 15 Mar 2014 | Past |
| Pramod Abcsdd | Director | 20 Sep 2006 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Rhydburg Pharmaceuticals Ltd, for the financial year ended 2023, experienced Minor drop in revenue, with a 8.47% decrease. The company also saw a substantial improvement in profitability, with a 18.8% increase in profit. The company's net worth moved up by a moderate rise of 3.4%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Rhydburg Pharmaceuticals had a promoter holding of 99.35% and a public holding of 0.65%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹85,000,000.00
₹396,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 Sep 2019 | Axis Bank Limited | ₹8.50 Cr | Open |
| 20 Jul 2020 | Axis Bank Limited | ₹4.50 M | Satisfied |
| 22 Feb 2018 | Hdfc Bank Limited | ₹9.40 Cr | Satisfied |
| 02 Jun 2017 | Sidbi | ₹5.00 M | Satisfied |
| 29 Jul 2015 | Small Industries Development Bank Of India | ₹1.00 Cr | Satisfied |
Explore comprehensive loan charge details -
Rhydburg Pharmaceuticals has a workforce of 200 employees as of Mar 21, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Rhydburg Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rhydburg Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Sovan Lal Subalchand Pal was appointed as a Director was appointed as a Director on 04 Jun 2025 & has been associated with this company since 6 months . was completed.
Progress on Rhydburg Pharmaceuticals Ltd last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Rhydburg Pharmaceuticals Ltd has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was recorded as a recent event.
The activity A charge registered on 20 Jul 2020 via Charge ID 100406818 with Axis Bank Limited was fully satisfied on 18 Oct 2022. was completed.
A charge registered on 11 Jun 2013 via Charge ID 10439697 with State Bank Of India was fully satisfied on 27 Oct 2021. was recorded as a recent event.
Progress on A charge registered on 22 Feb 2008 via Charge ID 10094516 with State Bank Of India was fully satisfied on 27 Oct 2021. was documented.
The CIN of Rhydburg Pharmaceuticals Ltd is U24231DL1987PLC028434.
Rhydburg Pharmaceuticals Ltd is headquartered at B-9, 1St Floor, Commercial Complex Dr. Mukharjee Nagar, Delhi-110009, Delhi, Delhi, 110009.
Rhydburg Pharmaceuticals Ltd was incorporated on 26 June 1987.
The current directors of Rhydburg Pharmaceuticals Ltd are
The primary industry of Rhydburg Pharmaceuticals Ltd is Manufacturing.
Rhydburg Pharmaceuticals Ltd is unlisted.
The authorized capital of Rhydburg Pharmaceuticals Ltd is ₹5.00 Cr, and the paid-up capital is ₹3.70 Cr.
The compliance status of Rhydburg Pharmaceuticals Ltd is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX